Clinical Trial Update: Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection [NA]

View source ↗

Summary

Clinical trial update indicating hyperhydration is being studied in children with Shiga toxin-producing Escherichia coli infection, with recruitment ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hemolytic Uremic Syndrome
• Shiga Toxin-producing Escherichia Coli Infection

Snippet

Sponsor: University of Calgary | Conditions: Shiga Toxin-Producing Escherichia Coli (E. Coli) Infection, Hemolytic-Uremic Syndrome | NA | Status: RECRUITING